Industry Verticals »

All Categories

Insights »

About TMR »

Clinical Trial Management System Market Outlook, 2019-2027

Clinical Trial Management System Market (Mode of Delivery - On-premise, Web-based, Cloud-based; Component- Software, Hardware, Services; Type - Enterprise-based, Site-based; End use - Pharmaceutical Industries, Contract Research Organizations, Health Care Providers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global clinical trials management system (CTMS)market for the historical period 2017–2018 and forecast period 2019–2027, rising demand for new therapies and increasing research and developmental activities to drive the global clinical trials management system market during the forecast period
  • According to the report, the global clinical trials management system market was valued at US$ 1.4 Bn in 2018 and is anticipated to expand at a CAGR of 10.5% from 2019 to 2027

Increasing Research and Development (R&D) Investment in Clinical Trials: Key Driver

  • Increase in R&D investment by the pharmaceutical, life science, and clinical research industries are propelling the CTMS market. R&D in the pharmaceutical industry has contributed to medical research and increased life expectancy.
  • According to UK Research and Innovation, the number of procedures carried out as part of research programmes in Medical Research Council (MRC)-owned establishments reported to the Home Office in 2018 was 268,032. This is 8% of the total of 3.52 million scientific procedures reported to the Home Office for that year.
  • According to World Health Organization (WHO), over the analysis period i.e. from 1999 to 2019, there was a steady growth for most WHO regions, in the number of newly recruiting trials registered on Clinical Trials Registry. However, in WHO’s Europe, Americas and Western Pacific regions, the number of such trials registered has increased at a much higher rate than in other regions. For example, in 2019 the number of trials registered in Western Pacific (16,675) was around 23 times higher than that in Africa (716)
  • New therapy developments in healthcare industry require clinical trial management systems to manage huge data involved in the process of clinical trials. It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing trials. It maintains planning, preparation, performance, and reporting of clinical trials, which include participant information, trial, and filing deadlines. It also provides up-to- date information, such as regulatory approvals and submission of progress reports. Thus, rise in R&D investment in the pharmaceutical industry is increasing demand for clinical trial management systems in the market.
fa global clinical trial management system market

Increasing prevalence of disease is supporting importing of clinical trials in different regions of the world: A Key Driver

  • Increase in prevalence of chronic diseases such as diabetes, cancer, and AIDS in different parts of the world has significantly increased the number of pipeline drugs that require extensive clinical trials before approval
  • According to the U.S. National Institute of Health, in 2012, the number of clinical trials stood at 75,088 in the U.S., 11,216 in Germany, 10,240 in France, 4,688 in China, and 5,108 in South Korea.
  • An article published by National Council of Biotechnology Information (NCBI), in 2013, stated that about 31% of the world’s clinical trials were performed in emerging countries such as China and India due to high prevalence of cancer, diabetes, and respiratory diseases. Additionally, various lifestyle associated diseases and genetic disorders in countries in the Middle East and North Africa have increased the need for enhanced clinical trials in the region.
  • According to the International Agency for Research on Cancer (IARC), globally an estimated 14.1 million new cancer cases and 8.2 million cancer-related deaths were registered in 2012.
  • Rise in prevalence of diseases has increased the development of new drugs for their treatment, thereby driving the demand for clinical trials management system (CTMS).

Longer approval time for clinical trials to Hamper Market

  • Pharmaceutical and biotechnology companies are under immense pressure to bring more therapeutic products to the market to counter revenue losses caused due to recent patent expiration of blockbuster drugs.
  • However, factors such as approval from the Institutional Review Board (IRB) or the Ethical Committee (EC), contract and budget negotiation and approval, availability of appropriate patient population, protocol design and refinement, and legal reviews can delay the drug approval process.
  • Pharmaceutical and biopharmaceutical companies are required to get approval from competent regulatory authorities in every country before starting a clinical trial. Timelines for regulatory approvals in different countries can vary from a week to more than 12 months.
  • Henceforth, the due to such reasons, the approval time is longer for clinical trials, which is a factor anticipated to hamper the growth of the clinical trial management system market

Global Clinical trials management system Market: Competitive Landscape

  • This report profiles major players in the global clinical trials management system market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Leading players operating in the global clinical trials management system market are
    • Oracle
    • Dassault Système
    • Parexel International Corporation
    • IBM
    • Cinven
    • Mednet
    • Microsoft
    • Apple Inc.
    • Wipro Limited
    • Bio-Optronics, Inc.
    • Cognizant
    • DSG, Inc.
    • Forte
    • Veeva Systems
    • DATATRAK Int

Global Clinical Trials Management System Market: Key Developments

Key players in the global clinical trials management system market are engaged in technologically advanced processes, launch of new services, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global clinical trials management system market. A few expansion strategies adopted by players operating in the global clinical trials management system market are:

  • In March, 2020, Mednet, a healthcare technology company, announced a new program to support research organizations conducting any type of immunology-related research, including clinical studies on COVID-19 vaccines, diagnostics and treatments. Mednet's comprehensive clinical data management system (CDMS) is designed to be highly flexible to enable fast and efficient study builds and execution of any type of clinical research. The new program is designed to make it even easier for research organizations to conduct imminent and urgent research projects. 
  • In June 2019, Dassault Systèmes and Medidata Solutions, Inc., leader of the digital transformation of the Life Sciences industry for clinical development, commercial, and real-world data intelligence, announced the signing of a definitive agreement for Dassault Systèmes to acquire Medidata to provide end-to-end approach to drug discovery, development, clinical testing, manufacturing, and commercialization.
  • In March 2015, the globally reputed contract research organization (CRO), Pharmaceutical Product Development, LLC (PPD) adopted Oracle’s CTMS solution and migrated the huge clinical trials data to Oracle’s CTMS product. Adoption of Oracle’s product helped PPD to lower the costs of clinical trials.

The report on the global clinical trials management system market discussed individual strategies, followed by company profiles of manufacturers of clinical trials management system. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global clinical trials management system market.

Global Clinical trials management system Market – Segmentation

Mode of Delivery

Cloud-based

On-premise

Web-based

Component

Hardware

Services

Software

Type

Enterprise-based

Site-based

End-user

Pharmaceutical Industries

Contract Research Organizations (CRO)

Health Care Providers

Region

North America

Europe

Asia Pacific

Rest of the World (RoW)

Frequently Asked Questions

What is the anticipated CAGR of the clinical trial management system market in the forecast period?

Clinical trial management system market is anticipated to grow at a CAGR of 10.5% during the forecast period

Which region is expected to project the highest market share in the global clinical trial management system market?

North America accounted for a major share of the global clinical trial management system market

What are the end-use segments in the clinical trial management system market?

The end-use segments in the clinical trial management system market are Pharmaceutical Industries, Contract Research Organizations, Health Care Providers

What are the key driving factors for the growth of the clinical trial management system market?

Rising demand for new therapies and increasing research and developmental activities to drive the global clinical trials management system market during the forecast period

Who are the key players in the global clinical trial management system market?

Key players in the global clinical trial management system market include DataTRAK International Inc., Parexel International Corporation, Bio-Optronics, Inc., Dassault Systèmes SE, MedNet GmbH, and International Business Machines Corporation

    1. Preface

       1.1. Report Scope and Market Segmentation

       1.2. Research Highlights

       1.3. Assumptions and Acronyms Used

    2. Research Methodology

    3. Executive Summary : Global Clinical Trial Management System Market 

    4. Market Overview

       4.1. Introduction

           4.1.1. Clinical Trial Management System Definition

           4.1.2. Key Industry Evolutions/ Developments

       4.2. Overview: Global Clinical Trial Management System (CTSM) Market

       4.3. Market Dynamics

           4.3.1. Drivers

           4.3.2. Restraints

           4.3.3. Opportunities

       4.4. Porter’s Five Force Analysis

       4.5. Product Pipeline

       4.6. Standards for data management in clinical trial study

    5. Global Clinical Trial Management System (CTMS) Market Analysis, by Mode of Delivery

       5.1. Introduction & Definition

       5.2. Key Findings 

       5.3. Market Value  Forecast By Mode of Delivery , 2017–2027

           5.3.1. On-premise

           5.3.2. Web-based

           5.3.3. Cloud-based

       5.4. Market Attractiveness By Mode of Delivery

    6. Global Clinical Trial Management System (CTMS) Market Analysis, by Component

       6.1. Introduction & Definition

       6.2. Key Findings 

       6.3. Market Value  Forecast By Component, 2017–2027

           6.3.1. Software

           6.3.2. Hardware

           6.3.3. Services

       6.4. Market Attractiveness By Components 

    7. Global Clinical Trial Management System (CTMS) Market Analysis, by Type

       7.1. Introduction & Definition

       7.2. Key Findings 

       7.3. Market Value  Forecast By Type, 2017–2027

           7.3.1. Enterprise-based

           7.3.2. Site-based

       7.4. Market Attractiveness By Type

    8. Global Clinical Trial Management System (CTMS) Market Analysis, by End-user

       8.1. Introduction & Definition

       8.2. Key Findings 

       8.3. Market Value  Forecast By End-user, 2017–2027

           8.3.1. Pharmaceutical Industries

           8.3.2. Contract Research Organizations

           8.3.3. Healthcare Providers

           8.3.4. Market Attractiveness By End-user

    9. Global Clinical Trial Management System (CTMS) Market Analysis, by Region

       9.1. Key Findings

       9.2. Market Value  Forecast By Region

           9.2.1. North America

           9.2.2. Europe

           9.2.3. Asia

           9.2.4. Rest of the World 

       9.3. Market Attractiveness by Region

    10. North America Clinical Trial Management System Analysis and Forecast

       10.1. Key Findings

       10.2. North America Clinical Trial Management System (CTMS) Market Overview

       10.3. Market Value Share By Country/Sub-regions

           10.3.1. U.S. 

           10.3.2. Canada

       10.4. Market Value Share By Mode of Delivery

           10.4.1. Cloud-based

           10.4.2. Web-based

           10.4.3. On-premise

       10.5. Market Value Share By Component

           10.5.1. Software

           10.5.2. Hardware

           10.5.3. Services

       10.6. Market Value Share By Type

           10.6.1. Enterprise-based

           10.6.2. Site-based

       10.7. Market Value Share By End-user

           10.7.1. Pharmaceutical Industries

           10.7.2. Contract Research Organizations

           10.7.3. Healthcare Providers 

       10.8. Market Attractiveness Analysis

           10.8.1. By Country/Sub-region

           10.8.2. By Mode of Delivery

           10.8.3. By Component

           10.8.4. By Type

           10.8.5. By End-user 

    11. Europe Clinical Trial Management System Analysis and Forecast

       11.1. Key Findings

       11.2. Europe Clinical Trial Management System (CTMS) Market Overview

       11.3. Market Value Share By Country/Sub-regions

           11.3.1. U.K. 

           11.3.2. France

           11.3.3. Germany

           11.3.4. Russia

           11.3.5. Poland

           11.3.6. Rest of Europe

       11.4. Market Value Share By Mode of Delivery

           11.4.1. Cloud-based

           11.4.2. Web-based

           11.4.3. On-premise

       11.5. Market Value Share By Component

           11.5.1. Software

           11.5.2. Hardware

           11.5.3. Services

       11.6. Market Value Share By Type

           11.6.1. Enterprise-based

           11.6.2. Site-based

       11.7. Market Value Share By End-user

           11.7.1. Pharmaceutical Industries

           11.7.2. Contract Research Organizations

           11.7.3. Healthcare Providers 

       11.8. Market Attractiveness Analysis

           11.8.1. By Country/Sub-region

           11.8.2. By Mode of Delivery

           11.8.3. By Component

           11.8.4. By Type

           11.8.5. By End-user 

    12. Asia Clinical Trial Management System Analysis and Forecast

       12.1. Key Findings

       12.2. Asia Clinical Trial Management System (CTMS) Market Overview

       12.3. Market Value Share By Country/Sub-regions

           12.3.1. China 

           12.3.2. South Korea

           12.3.3. Taiwan

           12.3.4. India

           12.3.5. Rest of Asia

       12.4. Market Value Share By Mode of Delivery

           12.4.1. Cloud-based

           12.4.2. Web-based

           12.4.3. On-premise

       12.5. Market Value Share By Component

           12.5.1. Software

           12.5.2. Hardware

           12.5.3. Services

       12.6. Market Value Share By Type

           12.6.1. Enterprise-based

           12.6.2. Site-based

       12.7. Market Value Share By End-user

           12.7.1. Pharmaceutical Industries

           12.7.2. Contract Research Organizations

           12.7.3. Healthcare Providers 

       12.8. Market Attractiveness Analysis

           12.8.1. By Country/Sub-region

           12.8.2. By Mode of Delivery

           12.8.3. By Component

           12.8.4. By Type

           12.8.5. By End-user  

    13. Rest of World (ROW) Clinical Trial Management System Market Analysis and Forecast

       13.1. Key Findings

       13.2. ROW Clinical Trial Management System (CTMS) Market Overview

       13.3. Market Value Share By Mode of Delivery

           13.3.1. Cloud-based

           13.3.2. Web-based

           13.3.3. On-premise

       13.4. Market Value Share By Component

           13.4.1. Software

           13.4.2. Hardware

           13.4.3. Services

       13.5. Market Value Share By Type

           13.5.1. Enterprise-based

           13.5.2. Site-based

       13.6. Market Value Share By End-user

           13.6.1. Pharmaceutical Industries

           13.6.2. Contract Research Organizations

           13.6.3. Healthcare Providers 

       13.7. Market Attractiveness Analysis

           13.7.1. By Mode of Delivery

           13.7.2. By Component

           13.7.3. By Type

           13.7.4. By End-user  

    14. Competition Landscape

       14.1. Market Player – Competition Matrix (By Tier and Size of companies)

       14.2. .Market Share Analysis By Company (2018)

       14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

           14.3.1. Oracle

               14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.1.2. Financial Overview

               14.3.1.3. Product Portfolio

               14.3.1.4. SWOT Analysis 

               14.3.1.5. Strategic Overview

           14.3.2. Dassault Système 

               14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.2.2. Financial Overview

               14.3.2.3. Product Portfolio

               14.3.2.4. SWOT Analysis 

               14.3.2.5. Strategic Overview

           14.3.3. PAREXEL International Corporation

               14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.3.2. Financial Overview

               14.3.3.3. Product Portfolio

               14.3.3.4. SWOT Analysis 

               14.3.3.5. Strategic Overview

           14.3.4. IBM 

               14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.4.2. Financial Overview

               14.3.4.3. Product Portfolio

               14.3.4.4. SWOT Analysis 

               14.3.4.5. Strategic Overview

           14.3.5. Cinven

               14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.5.2. Financial Overview

               14.3.5.3. Product Portfolio

               14.3.5.4. SWOT Analysis 

               14.3.5.5. Strategic Overview

           14.3.6. Mednet 

               14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.6.2. Financial Overview

               14.3.6.3. Product Portfolio

               14.3.6.4. SWOT Analysis 

               14.3.6.5. Strategic Overview

           14.3.7. Microsoft

               14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.7.2. Financial Overview

               14.3.7.3. Product Portfolio

               14.3.7.4. SWOT Analysis 

               14.3.7.5. Strategic Overview

           14.3.8. Apple Inc.

               14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.8.2. Financial Overview

               14.3.8.3. Product Portfolio

               14.3.8.4. SWOT Analysis 

               14.3.8.5. Strategic Overview

           14.3.9. Bio-Optronics, Inc.

               14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.9.2. Financial Overview

               14.3.9.3. Product Portfolio

               14.3.9.4. SWOT Analysis 

               14.3.9.5. Strategic Overview

           14.3.10. Cognizant 

               14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.10.2. . Financial Overview

               14.3.10.3. Product Portfolio

               14.3.10.4. SWOT Analysis 

               14.3.10.5. Strategic Overview

           14.3.11. DSG, Inc.

               14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.11.2. Financial Overview

               14.3.11.3. Product Portfolio

               14.3.11.4. SWOT Analysis 

               14.3.11.5. Strategic Overview

           14.3.12. Forte 

               14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.12.2. Financial Overview

               14.3.12.3. Product Portfolio

               14.3.12.4. SWOT Analysis 

               14.3.12.5. Strategic Overview

           14.3.13. Veeva Systems

               14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.13.2. Financial Overview

               14.3.13.3. Product Portfolio

               14.3.13.4. SWOT Analysis 

               14.3.13.5. Strategic Overview

           14.3.14. DATATRAK Int

               14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

               14.3.14.2. Financial Overview

               14.3.14.3. Product Portfolio

               14.3.14.4. SWOT Analysis 

               14.3.14.5. Strategic Overview

    List of Tables 

    Table 01: Global CTMS Market Size (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

    Table 02: Global CTMS Market Size (US$ Mn) Forecast, by Component, 2017–2027

    Table 03: Global CTMS Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 04: Global CTMS Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 05: Global CTMS Market (US$ Mn) Forecast, by Region, 2017–2027

    Table 06: North America Clinical Trial Management (CTMS) Market Size (US$ Mn) Forecast, by Country, 2017–2027

    Table 07: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

    Table 08: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2017–2027

    Table 09: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 10: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 11: Europe Clinical Trial Management (CTMS) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 12: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

    Table 13: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2017–2027

    Table 14: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 15: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 16: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 17: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

    Table 18: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Component, 2017–2027

    Table 19: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 20: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 21: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Mode of Delivery, 2017–2027

    Table 22: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Component, 2017–2027

    Table 23: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by Type, 2017–2027

    Table 24: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast, by End-user, 2017–2027

    Table 25: Market Footprint Analysis, by Region

    List of Figure

    Figure 1: Global Clinical Trial Management System Market Size ($ Million) and Distribution by Geography, 2018 and 2027

    Figure 2: Global Clinical Trial Management System Market, by Component and Mode of Delivery

    Figure 3: Global Clinical Trial Management System Market, by type and end-user

    Figure 4: Market Share by Region, 2018

    Figure 5: Global Clinical Trial Management System, Market Opportunity Map, by Mode of Delivery and Component

    Figure 6: Global Clinical Trial Management System, Market Opportunity Map, by Type and End-user

    Figure 7: Global Clinical Trial Management System (CTSM) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 8: Global CTMS Market Value Share, by Mode of Delivery, 2018 and 2027

    Figure 9: Global CTMS Market Attractiveness, by Mode of Delivery, 2019–2027

    Figure 10: Cloud-based Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 11: Web-based Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 12: On-premise Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 13: Global CTMS Market Value Share, by Component, 2018 and 2027

    Figure 14: Global CTMS Market Attractiveness, by Component, 2019–2027

    Figure 15: Software Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 16: Hardware Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 17: Services Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 18: Global CTMS Market Value Share, by Type, 2018 and 2027

    Figure 19: Global CTMS Market Attractiveness, by Type, 2019–2027

    Figure 20: Enterprise based Clinical Trial Management System

    Figure 21: Site based Clinical Trial Management System

    Figure 22: Global CTMS Market Value Share, by End-user, 2018 and 2027

    Figure 23: Global CTMS Market Attractiveness, by End-user, 2019–2027

    Figure 24: Pharmaceutical Industries Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 25: Contract Research Organizations Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 26: Health Care Providers Clinical Trial Management System Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 27: Global CTMS Market Value Share, by Region, 2018 and 2027

    Figure 28: Global CTMS Market Attractiveness, by Region, 2019–2027

    Figure 29: North America Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 30: North America Clinical Trial Management System (CTMS) Market Value Share, by Country, 2018 and 2027

    Figure 31: North America Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2019–2027

    Figure 32: North America Clinical Trial Management System (CTMS) Market Value Share, by Component, 2018 and 2027

    Figure 33: North America Clinical Trial Management System (CTMS) Attractiveness, by Component, 2019–2027

    Figure 34: North America Clinical Trial Management System (CTMS) Market Value Share, by Type, 2018 and 2027

    Figure 35: North America Clinical Trial Management System (CTMS) Attractiveness, by Type, 2019–2027

    Figure 36: North America Clinical Trial Management System (CTMS) Value Share, by End-user, 2018 and 2027

    Figure 37: North America Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2019–2027

    Figure 38: Europe Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019–2027

    Figure 39: : Europe Clinical Trial Management System (CTMS) Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 40: Europe Clinical Trial Management System (CTMS) Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 41: Europe Clinical Trial Management System (CTMS) Market Value Share, by Mode of Delivery, 2018 and 2027

    Figure 42: Europe Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2019–2027

    Figure 43: Europe Clinical Trial Management System (CTMS) Market Value Share, by Component, 2018 and 2027

    Figure 44: Europe Clinical Trial Management System (CTMS) Attractiveness, by Component, 2019–2027

    Figure 45: Europe Clinical Trial Management System (CTMS) Market Value Share, by Type, 2018 and 2027

    Figure 46: Europe Clinical Trial Management System (CTMS) Attractiveness, by Type, 2019–2027

    Figure 47: Europe Clinical Trial Management System (CTMS) Value Share, by End-user, 2018 and 2027

    Figure 48: Europe Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2019–2027

    Figure 49: Asia Clinical Trial Management Systems (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2019–2027

    Figure 50: : Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Country/Sub-region, 2018 and 2027

    Figure 51: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Country/Sub-region, 2019–2027

    Figure 52: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Mode of Delivery, 2018 and 2027

    Figure 53: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Mode of Delivery, 2019–2027

    Figure 54: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Component, 2018 and 2027

    Figure 55: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Component, 2019–2027

    Figure 56: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by Type, 2018 and 2027

    Figure 57: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by Type, 2019–2027

    Figure 58: Asia Clinical Trial Management Systems (CTMS) Market Value Share, by End-user, 2018 and 2027

    Figure 59: Asia Clinical Trial Management Systems (CTMS) Market Attractiveness, by End-user, 2019–2027

    Figure 60: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

    Figure 61: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Value Share, by Mode of Delivery, 2018 and 2027

    Figure 62: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Attractiveness, by Mode of Delivery, 2019–2027

    Figure 63: Rest of the World (RoW)Clinical Trial Management System (CTMS) Market Value Share, by Component, 2018 and 2027

    Figure 64: Rest of the World (RoW)Clinical Trial Management System (CTMS) Attractiveness, by Component, 2019–2027

    Figure 65: Rest of the World (RoW) Clinical Trial Management System (CTMS) Market Value Share, by Type, 2018 and 2027

    Figure 66: Rest of the World (RoW) Clinical Trial Management System (CTMS) Attractiveness, by Type, 2019–2027

    Figure 67: Rest of the World (RoW)Clinical Trial Management System (CTMS) Value Share, by End-user, 2018 and 2027

    Figure 68: Rest of the World (RoW)Clinical Trial Management System (CTMS) Attractiveness, by End-user, 2019–2027

    Figure 69: Global Clinical Trial Management System  Market Share Analysis, by Key Players (2018)

    Figure 70: Oracle’s Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 71: Breakdown of Oracle’s Revenue, by Region, 2018

    Figure 72: Breakdown of Oracle’s Revenue, by Business Segment, 2018

    Figure 73: Oracle’s Research & Development Expenditure (US$ Mn) and Intensity (%), 2018 and 2017

    Figure 74: Dassault Système Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 75: Dassault Système Revenue(US$ Mn), by Subscription Business Segment, 2018

    Figure 76: Dassault Système, Inc Revenue (US$ Mn), by Professional Services Business Segment, 2018

    Figure 77: Dassault Système, Inc R&D Expenditure (US$ Mn), 2017–2018

    Figure 78: PAREXEL International Corporation Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 79: PAREXEL International Corporation Revenue (US$ Mn), by Business Segment, 2018

    Figure 80: PAREXEL International Corporation Revenue (US$ Mn), by Geography, 2018

    Figure 81: PAREXEL International Corporation Selling, General and Administrative Expenditure (US$ Mn), 2017–2018

    Figure 82: IBM Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

    Figure 83: IBM Revenue (US$ Mn), by Subscription Business Segment, 2018

    Figure 84: IBM S,G&A Expenditure (US$ Mn), 2018

    Figure 85: IBM R&D Expenditure (US$ Mn), 2017–2018

    Figure 86: Microsoft Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 87: Microsoft Gross Margin (Bn) and Y-o-Y Growth (%), 2016-2018

    Figure 88: Microsoft Operating Income (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 89: Microsoft Assets (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 90: Apple Inc Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 91: Apple Inc Gross Margin (Bn) and Y-o-Y Growth (%), 2016-2018

    Figure 92: Apple Inc Net Income (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 93: R&D Expense (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 94: Wipro Limited Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018

    Figure 95: Wipro Limited Gross Income (Bn) and Y-o-Y Growth (%), 2016-2018

    Figure 96: Wipro Limited R&D Expenses  (US$ Bn) and Y-o-Y Growth (%), 2017–2018

    Figure 97: Cognizant Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 98: Cognizant Gross Income (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 99: Cognizant Revenue, by Business Segment, 2018

    Figure 100: Cognizant Revenue, by Geography, 2018

    Figure 101: Veeva Systems Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 102: Veeva Systems Gross Income (US$ Mn) and Y-o-Y Growth (%), 2016–2018

    Figure 103: Veeva Systems SG&A Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2018

    Figure 104: Veeva Systems R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2018

    Figure 105: DATATRAK Int Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 106: DATATRAK INT Gross Income (US$ Mn) & Y-o-Y Growth (%), 2016–2018

    Figure 107: DATATRAK Int SG&A Expenditure (US$ Mn), 2018

    Figure 108: DATATRAK Int Research & Development Expenditure (US$ Mn), 2018 and 2017

Copyright © Transparency Market Research, Inc. All Rights reserved

Clinical Trial Management System Market Outlook, 2019-2027

Schedule a Call